State of Wyoming’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLX
OM
SWP
State of Wyoming's PLX Position: Q4 2025 in Review
State of Wyoming sold out of Protalix BioTherapeutics (PLX) in Q4 2025, closing a stake of 39,018 shares — an estimated $86.6K sold.
State of Wyoming first reported a position in PLX in Q3 2023 and held it in 2 quarters. The position peaked at $86.6K in Q3 2025. 83 funds tracked by Wall St. Rank hold PLX as of Q4 2025.
- State of Wyoming reported no remaining Protalix BioTherapeutics position as of Q4 2025 after selling out during the quarter.
- State of Wyoming sold 39,018 Protalix BioTherapeutics shares in Q4 2025, an estimated $86.6K.
- State of Wyoming first reported a position in Protalix BioTherapeutics in Q3 2023 and held it in 2 quarters.
- State of Wyoming's Protalix BioTherapeutics position peaked at $86.6K in Q3 2025.
- 83 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q4 2025.
Based on State of Wyoming's 13F filing for Q4 2025, filed 11 Feb 2026.